Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke "SPARCL"
Completed
Phase 4 ResultsReferences
Publications
- Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006 Aug 10;355(6):549-59. Pubmed ID:16899775
Related Links
Sources for Trial Information
- Pfizer
- ClinicalTrials.gov
View Trial Locations
Recruitment
- Enrollment: 4,732
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 130 locations, 25 countries
Principal Investigator
- Pfizer CT.gov Call Center
Pfizer
